We’re #hiring! CARGO is looking for a Director of Regulatory Affairs. Your work in this cross-functional role will support our mission to impact patients worldwide through the development of next-generation CAR T-cell therapies. You can read more about the role here: https://lnkd.in/eAzCw9vs #biotechjobs #careers
CARGO Therapeutics
Biotechnology Research
San Carlos, California 12,969 followers
Outsmarting Cancer to Deliver More Cures
About us
CARGO Therapeutics is engineering best-in-class CAR T-cell therapy to overcome resistance to cancer treatment and address barriers to access so that more patients may benefit from potentially curative therapies. CARGO is on a mission to outsmart cancer by advancing a new generation of best-in-class chimeric antigen receptor (CAR) T-cell therapies. Despite advances made by commercially available autologous CARs, these treatments are curative for fewer than half of all cancer patients. In addition, far too many patients are unable to access these potentially curative therapies due to other challenges, including manufacturing, supply constraints, slow turnaround time and reimbursement hurdles. The team at CARGO is intensely focused on pursuing novel solutions to achieve better cancer treatment outcomes and experiences.
- Website
-
https://cargo-tx.com
External link for CARGO Therapeutics
- Industry
- Biotechnology Research
- Company size
- 51-200 employees
- Headquarters
- San Carlos, California
- Type
- Privately Held
- Founded
- 2021
Locations
-
Primary
835 Industrial Rd, Suite 400
San Carlos, California 94070, US
Employees at CARGO Therapeutics
-
Bethany Rogers
Results-driven cell therapy leader passionate about building an engaging culture, developing high-performing teams, and delivering impactful health…
-
Angela Haasch
Results driven, self-motivated professional with solid experience supporting executives in a fast pace environment.
-
Brett Masterson
Head of Marketing
-
Christophe Suchet
VP, Head of IT at CARGO Therapeutics
Updates
-
CARGO is #hiring a Senior Director of Talent Development. This newly created position will be responsible for leading, designing and implementing a comprehensive talent management and development strategy. Join our team and support our work to develop the next generation of transformational CAR T-cell therapies. Learn more here: https://lnkd.in/ecdiJQhN #careers #biotech
-
Congratulations to Stanford University School of Medicine investigators on the first peer-reviewed publication of their Phase 1 clinical study evaluating our lead candidate CD22 CAR T-cell therapy, firi-cel, in the The Lancet! These impactful findings continue to demonstrate the curative potential of firi-cel and support the study design of our currently enrolling Phase 2 program. Learn more: https://lnkd.in/dH_QQNmK #CART #celltherapy
-
The CARGO team is growing! We’re #hiring a Director of Biostatistics to join our team. Join us as we advance potentially transformative CAR T therapies to impact patients worldwide. Learn more about the role here: https://lnkd.in/e3V6DPia #careers #biotechnology
-
CARGO Therapeutics is #hiring a Senior Scientist in Analytical Development. In this role, you’ll contribute to the development of cell-based and molecular assays. Join us as we work to develop potentially curative CAR T therapies. Read more about the role here: https://lnkd.in/eK9YrtuA #careers #biotechnology
-
The CARGO team is #hiring a Clinical Project Manager. In this role, you’ll support early-phase clinical research trials. Your work will directly support CARGO’s mission to outsmart cancer through the development of next generation CAR T-cell therapies. Come join us! https://lnkd.in/ecdiJQhN #biotechjobs #celltherapy
-
We're thrilled to be featured in the 2024 New Era in Life Sciences Report published in Newsweek and Investment Reports, which highlights recent innovations and advancements in the field, including CARGO’s work to develop CAR T-cell therapies designed to address unmet patient needs: https://lnkd.in/diZsNp3i #celltherapy #CART
-
We’re pleased to announce the appointment of Jane Pritchett Henderson to our Board of Directors, adding strategic finance and broad biotech operating experience as we continue to execute our potentially pivotal Phase 2, FIRCE-1 clinical study, while advancing our CAR T pipeline. Learn more: https://lnkd.in/eQWfU3yc #CART #celltherapy
-
Join CARGO’s President and CEO Gina Chapman for a fireside chat at the Jefferies Global Healthcare Conference in New York City, on June 5 at 11:30 a.m. EST, where she will share our latest company highlights. Learn more here: https://lnkd.in/exiE5HCA #CART #JefferiesHealthcare #celltherapy
-
At CARGO, we are tenacious in the relentless pursuit of our mission to develop potentially curative treatments for more patients. We’re currently hiring an Associate Director, Statistical Programming, who will play a critical role in advancing our clinical development programs. Learn more: https://lnkd.in/e5UWD84e #biotechjobs #careers #CART